Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...

Strategy Without Execution Is Dead: The Hoshin Kanri Framework That’s Powering AI Leaders

If you’re building AI‑infused products and platforms, Hoshin Kanri gives you an operating system to turn strategic bets into ...